Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Acrivon Therapeutics (ACRV) Institutional Ownership

Acrivon Therapeutics logo
$1.36 +0.04 (+3.03%)
Closing price 04:00 PM Eastern
Extended Trading
$1.36 0.00 (0.00%)
As of 04:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Acrivon Therapeutics (NASDAQ:ACRV)

Current
Institutional Ownership
Percentage
71.62%
Number of
Institutional Buyers
(last 12 months)
18
Total
Institutional Inflows
(last 12 months)
$5.15M
Number of
Institutional Sellers
(last 12 months)
12
Total
Institutional Outflows
(last 12 months)
$3.39M
Get ACRV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acrivon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ACRV Institutional Buying and Selling by Quarter

Acrivon Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Bridgeway Capital Management LLC22,900$27K0.0%-70.6%0.073%
8/14/2025 Jane Street Group LLC311,829$371K0.0%N/A0.995%
8/13/2025 Marshall Wace LLP181,187$216K0.0%-59.8%0.578%
8/13/2025 Quadrature Capital Ltd22,175$26K0.0%N/A0.071%
8/12/2025 XTX Topco Ltd106,119$126K0.0%N/A0.338%
8/8/2025 Geode Capital Management LLC164,362$196K0.0%-46.3%0.524%
6/27/2025 Goldman Sachs Group Inc.57,519$117K0.0%-75.8%0.183%
5/16/2025 Goldman Sachs Group Inc.57,519$117K0.0%-75.8%0.183%
5/15/2025 Baker BROS. Advisors LP22,809$46K0.0%-56.9%0.073%
5/13/2025 Wealthedge Investment Advisors LLC56,467$115K0.1%+420.1%0.180%
5/12/2025 Nuveen LLC13,402$27K0.0%N/A0.043%
5/12/2025 Invesco Ltd.35,315$72K0.0%N/A0.113%
3/12/2025 Wealthedge Investment Advisors LLC10,857$65K0.0%N/A0.035%
2/17/2025Nuveen Asset Management LLC13,402$81K0.0%-48.0%0.043%
2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC102,784$619K0.0%+29.7%0.330%
2/17/2025 Corton Capital Inc.12,159$73K0.0%N/A0.039%
2/17/2025 Bridgeway Capital Management LLC74,600$449K0.0%-3.1%0.240%
2/17/2025 Citadel Advisors LLC2,119,646$12.76M0.0%-1.0%6.807%
2/17/2025 Acorn Capital Advisors LLC405,237$2.44M1.3%N/A1.301%
2/14/2025 Northern Trust Corp117,323$706K0.0%+11.3%0.377%
2/14/2025 Dimensional Fund Advisors LP37,063$223K0.0%+20.2%0.119%
2/13/2025 Marshall Wace LLP597,794$3.60M0.0%-26.2%1.920%
2/13/2025 Barclays PLC38,091$228K0.0%+14.4%0.122%
2/13/2025 Renaissance Technologies LLC49,400$297K0.0%+7.6%0.159%
2/12/2025 Trexquant Investment LP16,871$102K0.0%-44.5%0.054%
2/12/2025 JPMorgan Chase & Co.25,809$155K0.0%-24.1%0.083%
2/11/2025 American Century Companies Inc.17,588$106K0.0%+14.2%0.056%
2/6/2025 Charles Schwab Investment Management Inc.113,840$685K0.0%-2.1%0.366%
2/4/2025 Bank of New York Mellon Corp27,635$166K0.0%-6.4%0.089%
1/24/2025China Universal Asset Management Co. Ltd.6,602$40K0.0%N/A0.021%
12/26/2024 JPMorgan Chase & Co.33,991$238K0.0%+548.3%0.109%
12/13/2024 Exome Asset Management LLC116,757$817K0.5%N/A0.375%
11/19/2024 Barclays PLC33,306$233K0.0%+51.2%0.107%
11/16/2024 Geode Capital Management LLC302,103$2.12M0.0%-2.0%0.975%
11/15/2024 Barclays PLC33,306$233K0.0%+51.2%0.108%
11/15/2024 State Street Corp225,896$1.58M0.0%+26.4%0.729%
11/12/2024 Charles Schwab Investment Management Inc.116,253$814K0.0%-19.2%0.375%
10/10/2024 Exchange Traded Concepts LLC20,348$142K0.0%-52.5%0.066%
8/16/2024 Perceptive Advisors LLC5,360,858$31.09M0.7%+78.2%17.362%
8/14/2024 Marshall Wace LLP948,866$5.50M0.0%+58.8%3.073%
"I'm risking my reputation on this" (Ad)

A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That's why we've rushed to update our book "Crypto Revolution" – to show you exactly how to position yourself for this historic opportunity.tc pixel

Click here to claim your FREE copy now!
8/13/2024 Sands Capital Ventures LLC2,122,605$12.31M4.1%+28.4%6.874%
8/12/2024 XTX Topco Ltd10,493$61K0.0%N/A0.034%
8/9/2024 Renaissance Technologies LLC54,500$316K0.0%-46.9%0.177%
8/9/2024 Dimensional Fund Advisors LP10,066$58K0.0%N/A0.033%
8/1/2024 Rhumbline Advisers16,209$94K0.0%+48.9%0.052%
7/26/2024 Bank of New York Mellon Corp36,632$212K0.0%+50.1%0.119%
5/15/2024 Baker BROS. Advisors LP52,885$378K0.0%N/A0.234%
5/14/2024 American International Group Inc.6,016$43K0.0%+39.2%0.027%
5/10/2024 Vanguard Group Inc.507,185$3.63M0.0%+6.6%2.241%
1/5/2024 Exchange Traded Concepts LLC13,289$65K0.0%+34.0%0.060%
11/13/2023 Federated Hermes Inc.226,375$2.16M0.0%-25.6%1.020%
9/21/2023 Barclays PLC14,263$184K0.0%-16.0%0.065%
8/10/2023 AAF Wealth Management LLC10,678$138K0.1%N/A0.049%
7/20/2023 Exchange Traded Concepts LLC11,709$152K0.0%N/A0.053%
5/8/2023 Federated Hermes Inc.613,625$7.79M0.0%-25.5%2.798%
2/16/2023HealthCor Management L.P.284,201$3.27M3.0%N/A1.360%
2/14/2023 RA Capital Management L.P.4,810,508$55.42M1.1%N/A23.028%
2/13/2023 Sands Capital Ventures LLC1,652,605$19.04M5.2%N/A7.913%
2/10/2023 NEA Management Company LLC481,677$4.44M0.2%N/A2.306%
2/1/2023 Bank of Montreal Can42,444$545K0.0%N/A0.203%
(Data available from 1/1/2016 forward)

ACRV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ACRV shares?

During the previous two years, 35 institutional investors and hedge funds held shares of Acrivon Therapeutics. The most heavily invested institutionals were Perceptive Advisors LLC ($31.09M), Citadel Advisors LLC ($12.76M), Sands Capital Ventures LLC ($12.31M), Vanguard Group Inc. ($3.63M), Acorn Capital Advisors LLC ($2.44M), Federated Hermes Inc. ($2.16M), and State Street Corp ($1.58M).Learn more on Acrivon Therapeutics' institutional investors.

What percentage of Acrivon Therapeutics' stock is owned by institutional investors?

71.62% of Acrivon Therapeutics' stock is owned by institutional investors. Learn more on ACRV's institutional investor holdings.

Which institutional investors have been buying Acrivon Therapeutics' stock?

Of the 27 institutional investors that purchased Acrivon Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($2.35M), Sands Capital Ventures LLC ($470K), Acorn Capital Advisors LLC ($405.24K), Marshall Wace LLP ($351.40K), Jane Street Group LLC ($311.83K), Exome Asset Management LLC ($116.76K), and XTX Topco Ltd ($116.61K).

How much institutional buying is happening at Acrivon Therapeutics?

Institutional investors have bought a total of 1,236,759 shares in the last 24 months. This purchase volume represents approximately $5.15M in transactions.

Which of Acrivon Therapeutics' major shareholders have been selling company stock?

Of the 12 institutional investors that sold Acrivon Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Marshall Wace LLP ($481.27K), Goldman Sachs Group Inc. ($360.07K), Geode Capital Management LLC ($148.04K), Bridgeway Capital Management LLC ($57.38K), Charles Schwab Investment Management Inc. ($30.12K), Baker BROS. Advisors LP ($30.08K), and Exchange Traded Concepts LLC ($22.52K).

How much institutional selling is happening at Acrivon Therapeutics?

Institutional investors have sold a total of 1,186,392 shares in the last 24 months. This volume of shares sold represents approximately $3.39M in transactions.


Related Companies

This page (NASDAQ:ACRV) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners
What Steve Bannon revealed about Trump’s gold play
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...
Reagan Gold Group | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
BREAKING: The House just passed 3 pro-crypto bills!
The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...
Crypto 101 Media | Sponsoredtc pixel
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...
InvestorPlace | Sponsoredtc pixel
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsoredtc pixel